Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events
Frontiers in Child and Adolescent Psychiatry · 17.02.2026 · 5
DOI: 10.3389/frcha.2026.1731268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Child and Adolescent Psychiatry, online erschienen am 17.02.2026. Verfasst von Jesús Alonso Gándara-Mireles und 7 weiteren Autor:innen. Beteiligte Einrichtung: CIIDIR-Durango Unit, National Polytechnic Institute, Genomics Academy, Durango, Mexico. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Anxiety disorders in the pediatric population represent a highly prevalent mental health concern whose pharmacological management has been consolidated through the use of selective serotonin reuptake inhibitors (SSRIs). Among these agents, sertraline is one of the most frequently prescribed; however, its efficacy and safety in children and adolescents exhibit substantial interindividual variability, largely attributed to clinical, physiological, and genetic factors. This review aimed to analyze the current evidence on the efficacy, safety, and optimization strategies for sertraline therapy in pediatric patients, with a particular focus on pharmacokinetic and pharmacogenetic determinants that modulate therapeutic response. Available evidence indicates that genetic variants in CYP2C19, CYP2D6, and ABCB1 significantly influence hepatic metabolism, plasma exposure, and drug tolerability. These differences support the integration of pharmacogenetic testing as a clinical tool to individualize dosing and prevent adverse effects. In addition, population pharmacokinetic modeling has emerged as a valuable approach to design personalized therapeutic regimens, especially for patients with medical comorbidities or atypical metabolic profiles. In conclusion, the integration of clinical, genetic, and pharmacokinetic information into pediatric psychiatric practice may facilitate the advancement of precision medicine, promoting safer, more effective, and individualized sertraline-based treatments for anxiety disorders in children and adolescents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CIIDIR-Durango Unit, National Polytechnic Institute, Genomics Academy, Durango, Mexico.
- Latin American Network for the Implementation and Validation of Pharmacogenomic Clinical Guidelines (RELIVAF-CYTED), Santiago, Chile.
- Faculty of Medicine and Nutrition, Juárez University of the State of Durango, Durango, Mexico.
- School of Medicine and Psychology, Autonomous University of Baja California, Tijuana, Mexico.
Zitieren
APA
Gándara-Mireles, J. A., Loera Castañeda, V., Lares-Asseff, I., Grijalva Ávila, J. C., Rosales Ramos, M. M., Villanueva Fierro, I., Patrón Romero, L., & Almanza Reyes, H. (2026). Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events. Frontiers in Child and Adolescent Psychiatry, 5. https://doi.org/10.3389/frcha.2026.1731268
Vancouver
Gándara-Mireles JA, Loera Castañeda V, Lares-Asseff I, Grijalva Ávila JC, Rosales Ramos MM, Villanueva Fierro I, et al. Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events. Frontiers in Child and Adolescent Psychiatry. 2026;5. doi:10.3389/frcha.2026.1731268
BibTeX
@article{GndaraMireles2026,
author = {Gándara-Mireles, Jesús Alonso and Loera Castañeda, Verónica and Lares-Asseff, Ismael and Grijalva Ávila, Julio Cesar and Rosales Ramos, Maria Magdalena and Villanueva Fierro, Ignacio and Patrón Romero, Leslie and Almanza Reyes, Horacio},
title = {Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events},
journal = {Frontiers in Child and Adolescent Psychiatry},
year = {2026},
volume = {5},
doi = {10.3389/frcha.2026.1731268}
}
EUVIMED